Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Compliance/Legal Officer

Chief Med. & Reg. Officer

Chief Commercial Officer

President and CEO

Chief Strategy Officer

Chief Op. & Scientific Officer

VP, Treasurer and CFO

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for peop...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-08	Premium	sold	Premium	Premium	Premium	-
2024-04-08	Premium	acquired	Premium	Premium	Premium	-
2024-03-27	Premium	sold	Premium	Premium	Premium	Chief Compliance/Legal Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Med. & Reg. Officer
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Compliance/Legal Officer
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Med. & Reg. Officer
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Strategy Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	-
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Compliance/Legal Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Op. & Scientific Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	-
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Strategy Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	-
2024-02-15	Premium	acquired	Premium	Premium	Premium	-
2024-02-05	Premium	acquired	Premium	Premium	Premium	-
2024-01-30	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	acquired	Premium	Premium	Premium	-
2023-12-27	Premium	acquired	Premium	Premium	Premium	VP, Treasurer and CFO
2023-12-27	Premium	acquired	Premium	Premium	Premium	Chief Op. & Scientific Officer

CPRX - Catalyst Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CPRX